Cardiovascular and Hormonal Research Laboratory
The Cardiovascular and Hormonal Research Laboratory has a clinical and translational research focus. It investigates the sex differences in heart disease, and examines the measurement and management of blood pressure.
The research lab is positioned within the Kolling Institute at Royal North Shore Hospital, ensuring research progress directly influences clinical care. It also ensures patient experiences inform the direction of research activity.
Our current projects target the following research areas:
- Understanding how steroid hormone receptors are regulated in the heart
- Sex differences in heart disease and hypertension
- Accurate measurement of blood pressure by both equipment validation and education
- Blood pressure variability and phenotyping hypertension
Measurement of blood pressure a key priority following "Global Burden of Disease": 2019, Lancet - systolic BP is the #1 risk factor for death and disability in women.
The Cardiovascular and Hormonal Research Laboratory is led by Dr Anastasia Mihailidou.
Dr Mihailidou was recently recognised by the Lancet with her appointment to the Commission on Cardiovascular Disease in Women. Nationally, her work has informed clinical practice through the development of the Australian Guidelines for Ambulatory Blood Pressure Monitoring.
Dr Mihailidou has been part of the select committee preparing an application for a Medicare rebate for ambulatory blood pressure monitoring. The translational focus of the Cardiovascular and Hormonal Research Laboratory has led to both national and international collaborations involving research teams in Egypt, Europe and Hong Kong.
Bachelor of Clinical Science students from Macquarie University presentations for the Professional and Community
Engagement (PACE) Activity between Macquarie University and NSLHD.